Semaglutide + Cagrilintide
Weight Loss (GLP-1)Known as CagriSema, this combination pairs a GLP-1 agonist with an amylin analog for enhanced weight loss. Currently in clinical trials by Novo Nordisk.
Starting from
$125.00
Vendors tracked
1
Prices updated
Jul 7, 2026
Compare Prices
Hydro Research15% OFF
Price
$106.25
$125.00
Per mg
$21.25
Size
5mg
Hydro Research15% OFF | — | $106.25$125.00 | 5mg | $21.25 | Yes |
Prices verified as of July 7, 2026
Quick Summary
Novo Nordisk's next-gen weight-loss combo (CagriSema) — pairs Wegovy's active ingredient with an appetite suppressor for even greater fat loss than either alone. Available from 1 vendor, starting at $125.00.
Research: In the Phase 3 REDEFINE 1 trial (n=3,417), CagriSema achieved 20.4% mean weight loss at 68 weeks, with 60% losing at least 20% and 88% of prediabetic participants returning to normal blood sugar.
Side effects: Nausea, Vomiting, Diarrhea, Constipation, Injection site reactions
Phase 3Novo Nordisk filed for FDA approval Dec 2025 as CagriSema
- 1 of 1 vendor currently have it in stock
- Most common vial size: 5mg
- Category: Weight Loss (GLP-1) — GLP-1 receptor agonists for weight management
Get Semaglutide + Cagrilintide price alerts
We'll email you when prices drop or new vendors are added.